Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

Mediastinal Thymic Carcinoma

Become part of our growing rare cancer community.
Join our Facebook support group

Join Now

Posted by fatima.shakeel@opmc.co | Oct 14, 2024

What is Mediastinal Thymic Carcinoma?

Mediastinal thymic carcinoma is a cancerous tumour that originates in the thymus gland, located in the mediastinum (the area between the lungs). There are two main types of thymic tumours:

  • Thymoma: These tumours tend to grow slowly.
  • Thymic Carcinoma: These tumours are more aggressive and can spread rapidly to other parts of the body.

The 5-year survival rate for patients with mediastinal thymic carcinoma is around 35%, and approximately 28% survive for at least 10 years.

Causes of Mediastinal Thymic Carcinoma

The exact cause of mediastinal thymic carcinoma is not well understood. However, certain hereditary and genetic conditions, such as Myasthenia Gravis and paraneoplastic syndromes, are believed to increase the risk of developing this type of cancer.

Signs and Symptoms

Patients with mediastinal thymic carcinoma may experience the following symptoms:

  • Chest pain
  • Shortness of breath or difficulty breathing
  • Persistent cough
  • Hoarseness or changes in the voice
  • Swelling in the face, arms, neck, or upper body

Diagnosis

Several diagnostic techniques can be used to confirm mediastinal thymic carcinoma, including:

  • Physical Examination: Doctors may look for any unusual lumps or masses in the neck and chest area.
  • Imaging Tests: Ultrasonography (USG), CT scans, MRI, and X-rays are used to determine the size, location, and extent of the tumour.
  • CT Scan: This can also help check if the cancer has spread to other parts of the body.
  • Biopsy: A small sample of tissue is taken for lab testing to confirm the presence of cancer. This may involve cutting or removing a suspicious tissue sample.
  • Tumour Markers and Sputum Cytology: Additional tests, including cytology, may be used to analyse the tumour cells.
  • USG-Guided Fine Needle Aspiration Cytology: A needle is used to take a tissue sample under ultrasound guidance.

Treatment

The primary treatment for mediastinal thymic carcinoma is surgical removal of the tumour with clear margins, which means ensuring that no cancer cells are left at the edges of the removed tissue. Surgery is often followed by radiation therapy to reduce the risk of cancer recurrence. Other treatment options include chemotherapy, immunotherapy, and targeted therapy, depending on the stage and spread of the disease.


You can help us with your donation:

Without a Ribbon is a charity that works hard to aid those who suffer from rare cancers. You can help our cause in a variety of ways:

Donations — Without a Ribbon is grateful when we receive every donation. Giving to Without a Ribbon helps us to provide ongoing support, organise the annual gathering and subsidise the costs of our Warriors attending these conferences.
 
Sponsorship — If you wish to sponsor our charity, please contact us using this form.
 
Volunteering — We are always looking for volunteers to help with different aspects of running our charity. So, if you are looking for volunteer work, please feel free to contact us.

Share:

PreviousSpermatocytic Seminoma of the Testis
NextOur New Resource Page for Mediastinal Thymic Carcinoma

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter